1.
Herald of Medicine
; (12): 732-735, 2016.
Artigo
em Chinês
| WPRIM
| ID: wpr-492960
RESUMO
Infection diseases induced by bacteria continue to be one of the greatest health problems worldwide. In this framework, nanotechnology-based solutions, and in particular silver nanoparticles ( AgNPs) , have recently emerged as promising candidates in the market as new antibacterial agents because of the enhanced broad-range antibacterial/antiviral properties and low cost.Here we analyze the experimental conclusions on the bactericidal effects of AgNPs, and discuss the safety issues.